| Pharmaceutical active ingredients: |
| MeloxicamMethocarbamol |
| Available forms, composition and doses of Dolocam Plus: |
| Capsules; Oral; Meloxicam 15 mg; Methocarbamol 215 mgCapsules; Oral; Meloxicam 7.5 mg; Methocarbamol 215 mg |
| Dolocam Plus medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AC56 - Meloxicam, combinationsM03BA53 - Methocarbamol, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Representaciones e Investigaciones Medicas |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Desparasil | Piperazine Hydrate | Representaciones e Investigaciones Medicas |
| Diabamet | Metformin Hydrochloride; Pioglitazone Hydrochloride | Representaciones e Investigaciones Medicas |
| Diaberil | Glimepiride; Pioglitazone Hydrochloride | Representaciones e Investigaciones Medicas |
| Diarim | Nifuroxazide | Representaciones e Investigaciones Medicas |
| Dolocam | Meloxicam | Representaciones e Investigaciones Medicas |
| Dolocartigen | Diacerein; Meloxicam | Representaciones e Investigaciones Medicas |
| Ephotin | Epoetin Alfa | Representaciones e Investigaciones Medicas |
| Ergex | Cisapride; Ranitidine | Representaciones e Investigaciones Medicas |
| Febrim | Acetaminophen | Representaciones e Investigaciones Medicas |
| Gentarim | Gentamicin Sulfate | Representaciones e Investigaciones Medicas |